Therapeutic Advances in Other Targetable Oncogenic Driver Mutations in NSCLC - Jin-Hyoung Kang
Document ID: SC-VN-01200
25/05/2021
Author: Boehringer Ingelheim
123,000
Views
100k 340
RELATED CONTENT
SC-VN-01200
Production date: May 2021
Production date: May 2021